281 related articles for article (PubMed ID: 22200856)
1. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MAT3 gene expression in NSCLC.
Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Med Oncol; 2012 Jun; 29(2):648-55. PubMed ID: 21519871
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
[TBL] [Abstract][Full Text] [Related]
5. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
Anagnostou VK; Lowery FJ; Zolota V; Tzelepi V; Gopinath A; Liceaga C; Panagopoulos N; Frangia K; Tanoue L; Boffa D; Gettinger S; Detterbeck F; Homer RJ; Dougenis D; Rimm DL; Syrigos KN
BMC Cancer; 2010 May; 10():186. PubMed ID: 20459695
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
[TBL] [Abstract][Full Text] [Related]
7. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH
World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancer.
Kim NY; Pyo JS
Pathol Res Pract; 2017 Jul; 213(7):778-782. PubMed ID: 28554757
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of D2-40 in non-small cell lung cancer.
Min KH; Park SJ; Lee KS; Hwang SH; Kim SR; Moon H; Han HJ; Chung MJ; Lee YC
Lung; 2011 Feb; 189(1):57-63. PubMed ID: 21107593
[TBL] [Abstract][Full Text] [Related]
11. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
12. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
13. Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis.
Chen D; Shen C; Du H; Zhou Y; Che G
Fam Cancer; 2014 Sep; 13(3):449-57. PubMed ID: 24609521
[TBL] [Abstract][Full Text] [Related]
14. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I
Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578
[TBL] [Abstract][Full Text] [Related]
15. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
18. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer.
Feng J; Zhang X; Zhu H; Wang X; Ni S; Huang J
Am J Clin Pathol; 2012 Aug; 138(2):230-5. PubMed ID: 22904134
[TBL] [Abstract][Full Text] [Related]
19. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
20. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.
Ritter JH; Dresler CM; Wick MR
Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]